A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)

作者：Viudez Antonio^*; Carvalho Filipe L F; Maleki Zahra; Zahurak Marianna; Laheru Daniel; Stark Alejandro; Azad Nilofer Z; Wolfgang Christopher L; Baylin Stephen; Herman James G; De Jesus Acosta Ana

来源：Oncotarget, 2016, 7(18): 24950-24961.

DOI：10.18632/oncotarget.7436

• pancreatic neuroendocrine tumor
• MGMT
• NDRG-1
• PHLDA-3
• immunohistochemistry

Pancreatic neuroendocrine tumor (PanNET) is a neoplastic entity in which few prognostic factors are well-known. Here, we aimed to evaluate the prognostic significance of N-myc downstream-regulated gen-1 (NDRG-1), O6-methylguanine DNA methyltransferase (MGMT) and Pleckstrin homology-like domain family A member 3 (PHLDA-3) by immunohistochemistry (IHC) and methylation analysis in 92 patients with resected PanNET and follow-up longer than 24 months. In multivariate analyses, ki-67 and our immunohistochemistry prognostic score (IPS-based on MGMT, NDRG-1 and PHLDA-3 IHC expression) were independent prognostic factors for disease-free-survival (DFS), while age and IPS were independent prognostic factors for overall survival (OS). Our IPS could be a useful prognostic biomarker for recurrence and survival in patients following resection for PanNET.

• 出版日期2016-5-3